Search

everythinglearnresearchcommunity

for

Search:↓

High doses of cyproterone acetate increase the risk of brain tumors in women, but the risk decreases after stopping the medication.

Short-term testosterone therapy in women seems safe with few mild side effects, but long-term effects need more research.

Early onset baldness in men may indicate a condition similar to PCOS, linked to heart disease, diabetes, and prostate issues.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

The normal human prostate does not significantly affect blood DHT levels.

Late diagnosis of congenital adrenal hyperplasia can greatly affect physical development, gender identity, and sexual health.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Male hormones cause different growth in identical human hair follicles due to their unique epigenetic characteristics.

Hormones and their receptors, especially androgens, play a key role in hair growth and disorders like baldness.

Stem cell therapy is a promising approach for hair regrowth despite potential side effects.

The congress highlighted new gene therapy techniques and cell transplantation methods for treating diseases.

Regenerated fully functional hair follicles using stem cells, with potential for hair regrowth therapy.

Stem cell research and regenerative medicine have made significant advancements in treating various diseases and conditions.

Dihydrotestosterone changes some hormone-related gene expressions in rat pituitary glands but doesn't affect the estrous cycle.

Androgenetic alopecia treatments are becoming more personalized and include new therapies like topical antiandrogens and regenerative strategies.

Hair ages due to various factors and treatments like minoxidil and finasteride can help, but more research and better public awareness are needed.

The document concludes that new treatments for hair loss may involve a combination of cosmetics, clinical methods, and genetic approaches.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Photothermal hydrogels are promising for infection control and tissue repair, and combining them with other treatments could improve results and lower costs.

Nanoparticles can be used to deliver drugs to hair follicles, potentially improving treatments for conditions like acne and alopecia, and could also be used for vaccine delivery and gene therapy.

Using a gene therapy with the Sonic Hedgehog gene helps mice regrow hair faster after losing it from chemotherapy.

The Apc gene is crucial for normal skin and thymus development.

Future research on ectodysplasin should explore its role in diseases, stem cells, and evolution, and continue developing treatments for genetic disorders like hypohidrotic ectodermal dysplasia.

Polyamines are important for hair growth, but more research is needed to understand their functions and treatment potential.

Mice genetically modified to produce more CD109 in their skin had less inflammation and better healing with less scarring.

Young transgender, gender diverse, and nonbinary people on spironolactone have a low risk of high potassium, so frequent monitoring may not be needed.

Transgender individuals face insurance barriers to gender-affirming surgery, needing policy reforms for better access.

Cells that move well may improve hair loss treatments by entering hair follicles.

Gender-affirming hormone treatments need better patient-focused outcome measurements and standardized data collection.